Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Structure Therapeutics Reports Phase 1 and 72-Week Weight Loss Data

Structure Therapeutics Inc. filed a Form 8-K with the SEC on September 8, 2026, disclosing positive topline clinical trial results for two oral small molecule programs targeting chronic weight management: ACCG-2671 and aleniglipron.

Aakashdeep | 08 September 2026

Agilent Technologies Board Chair Retires, New Director Named

Agilent Technologies, Inc. filed a Form 8-K with the SEC on September 8, 2026, disclosing that Board Chairperson Boon Hwee Koh retired from the Board effective September 4, 2026, and that Glenn Boehnlein was appointed to fill the resulting vacancy on the same date.

Aakashdeep | 08 September 2026

Rimini Street Chief Revenue Officer Resigns

Rimini Street, Inc. filed a current report on September 8, 2026, disclosing the resignation of its Executive Vice President and Chief Revenue Officer and the transfer of those responsibilities to its existing Chief Operating Officer.

Shwetambri Chauhan | 08 September 2026

Parker-Hannifin Boosts Credit Facility to $5 Billion

Parker-Hannifin Corporation filed an 8-K on September 8, 2026, disclosing a new $5.0 billion revolving credit agreement entered on September 4, 2026, a matching increase to its commercial paper program, and plans for a $2.0 billion delayed draw term loan tied to its pending …

Anjali Anand | 08 September 2026

First Citizens BancShares Completes 138-Branch Acquisition from BMO

First Citizens BancShares, Inc. filed a Form 8-K on September 8, 2026, reporting that its wholly owned banking subsidiary, First-Citizens Bank & Trust Company, completed its previously announced acquisition of 138 branches from BMO Bank N.A., effective September 4, 2026.

Aditi Sarkar | 08 September 2026

Markel Group Names Gayner Chairman, Adds Two Co-Presidents

Markel Group Inc. filed a Form 8-K on September 8, 2026, disclosing the planned retirement of Chairman Steven A. Markel, the appointment of Thomas S. Gayner as Chairman, the elevation of two executives to Co-President roles, and related base salary increases effective the same …

Aditi Sarkar | 08 September 2026

Mirum Pharmaceuticals Names New Chief Medical Officer

Mirum Pharmaceuticals, Inc. filed a Form 8-K on September 8, 2026, disclosing the appointment of Rob Myers, M.D., as Chief Medical Officer and the planned departure of Joanne Quan, M.D., from that role, effective September 2, 2026.

Shwetambri Chauhan | 08 September 2026

Elmet Group Signs Deal to Acquire OSRAM Tungsten and Molybdenum Assets

The Elmet Group Co. filed a Form 8-K on September 8, 2026, disclosing that its wholly owned subsidiary, Elmet Technologies LLC, entered into an Asset Purchase Agreement on September 3, 2026, to acquire substantially all assets of OSRAM GmbH's metal production operations in Schwabmünchen, …

Vinay Lochav | 08 September 2026

VICI Properties Appoints John M. Sullivan to Board

VICI Properties Inc. filed a Form 8-K on September 8, 2026, announcing the appointment of John M. Sullivan as an independent director to its Board of Directors, effective upon satisfaction of certain conditions including receipt of all applicable regulatory approvals.

Aakashdeep | 08 September 2026

Bitmine Immersion Technologies Terminates Ethereum Staking Management Agreement

Bitmine Immersion Technologies, Inc. filed a Form 8-K on September 8, 2026, disclosing the mutual termination of a Management Services Agreement with Ethereum Tower LLC and the simultaneous entry into a new, simplified services agreement for its Ethereum staking operations.

Vinay Lochav | 08 September 2026
Support

Hi! How can we help you today?

Loading…